TSE:4528Pharmaceuticals
Assessing Ono Pharmaceutical (TSE:4528) Valuation After Improved Nine Month Earnings
Why Ono Pharmaceutical’s latest earnings matter for shareholders
Ono Pharmaceutical (TSE:4528) has drawn fresh attention after reporting nine month results to December 31, 2025, with sales of ¥397,036 million and net income of ¥68,949 million, both above the prior year period.
See our latest analysis for Ono Pharmaceutical.
The latest nine month earnings update appears to have supported sentiment, with a 1 day share price return of 1.26% and a 30 day share price return of 11.03%. The 1 year...